View More
In this interactive program, Raymond T. Chung, MD, reviews current challenges with HCV therapies, describes novel classes of anti-HCV agents and their anticipated benefits for patients, and walks through a series of cases designed to evaluate the question of treating now vs waiting for future HCV therapies.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.